4 August 2017

Two great research institutes join forces – Garvan-Weizmann Centre for Cellular Genomics officially opened

The Garvan Institute of Medical Research, Sydney, and Weizmann Institute of Science, Rehovot, Israel, have now officially opened the Garvan-Weizmann Centre for Cellular Genomics – where the genetic makeup of thousands of individual cells can be studied at one time.

Situated at the Garvan, the Centre is the only one of its kind in Australia, housing a range of new and cutting-edge technologies to study cells more closely than ever before. Here researchers will be able to explore thousands of individual cells simultaneously: uncovering each cell’s genome sequence and its genetic output, understanding what makes it unique and exploring how it functions in health and disease.

Cellular genomics has only recently become feasible, uncovering thousands of pieces of information about each individual cell, instead of averaging information from a large group of cells (such as a tissue or a tumour biopsy).  It therefore has extraordinary potential to revolutionise understanding of many diseases and develop personalised medicine approaches.

“This remarkable new Centre is a seamlessly integrated one-stop shop. We’ve brought together key intersecting technologies that together make cellular genomics a reality. It’s only when these technologies – and, crucially, the people who can use them to best advantage – are available under one roof that they can speed the process of biomedical research,” said Professor Chris Goodnow, Deputy Director of the Garvan Institute.

“What makes the partnership even more momentous is that the Weizmann Institute is a global leader in multidisciplinary basic research, whereas Garvan’s focus is on translational research. Together, we are answering some of science and medicine’s greatest questions,” he said.

According to Professor Michal Neeman, Vice President of the Weizmann Institute of Science, they are entering uncharted territory.

“The technology within the Garvan-Weizmann Centre for Cellular Genomics is exceedingly demanding, and at the cutting edge. It’s enabling researchers to enter uncharted territories in terms of what is possible, to unlock new understanding in cancer and other diseases that could lead to treatments,” said Professor Neeman.

NSW Premier Gladys Berejiklian, who officially opened the Garvan-Weizmann Centre, said the NSW Government played an important role in establishing the Garvan-Weizmann Centre for Cellular Genomics.

“It is testament to NSW’s science leadership that we have the technology and expertise within the Centre right here in Sydney that can be made available to researchers across the globe,” she said.

Weizmann-Australia’s Executive Director, Rina Michael, who attended the official proceedings, said that it was the start of a scientific relationship that will be second to none.

“Garvan is a leader in the analysis of genomes and their behaviour and is at the forefront of genome sequencing in Australia, while the Weizmann Institute has outstanding expertise in single-cell genomics and in other key emerging technologies.  This partnership is a perfect match towards achieving significant, tangible outcomes for the benefit of humanity. We are very proud to be a part of it,” Ms Michael said.

The Centre’s initial projects will focus on cancer (particularly breast cancer, melanoma, prostate cancer and multiple myeloma), on autoimmune diseases (including rheumatoid arthritis, lupus and multiple sclerosis to name a few, and on cancer immunotherapies.

The Garvan and Weizmann Institutes established the Centre as part of a broader partnership which aims to advance biomedical research, genomic medicine and genomic education.

The construction of the Centre was made possible through visionary philanthropic support from Mr John Roth and Ms Jillian Segal AM, Mr and Mrs Laurie and Di Sutton and The Johnny Kahlbetzer Family and a grant from the Government of New South Wales.

Watch the video here,

  • Weizmann Australia Executive Director, Rina Michael and Weizmann Institute of Science's Vice President, Michal Neeman

  • Garvan's Deputy Executive Director, Professor Chris Goodnow and Weizmann Institute of Science's Vice President, Professor Michal Neeman

  • Garvan's Executive Director, Professor John Mattick, Jillian-Segal AM and John Roth

  • Garvan's Executive Director, Professor John-Mattick, Weizmann Institute of Science's Vice President, Professor Michal Neeman, Jillian Segal AM and NSW Premier Gladys Berejiklian

  • Weizmann Institute of Science's Vice President, Professor Michal Neeman and Garvan's Executive Director, Professor-John Mattick

  • Weizmann Australia Executive Director, Rina Michael and Garvan's Deputy Executive Director

Recent blog posts

view all +

17 September 2020 | Videos, Weizmann in Israel

Bacteria Could Provide Us with the Next Antivirals

By tracking the evolution of what may be our oldest means of fighting off viral infection, a group at the Weizmann Institute of Science has uncovered a gold mine of...

read more +

16 September 2020 | Weizmann in Israel

Profiling COVID-19

A research team at the Weizmann Institute of Science and Israel Institute for Biological Research, in Ness Ziona, Israel, has a new approach to understanding the COVID-19 virus that may...

read more +

9 September 2020 | Weizmann in Israel, Weizmann in the News

Young at Heart: Restoring Cardiac Function with a Matrix Molecule

Pre-clinical studies at the Weizmann Institute of Research suggest a protein called Agrin could limit scarring and promote natural repair mechanisms after a heart attack. Heart disease is the number...

read more +